论文信息 - Absence of somatic mutations of the mTOR gene in differentiated thyroid cancer - 字舞流文

Absence of somatic mutations of the mTOR gene in differentiated thyroid cancer

A. Alzahrani | H. Al-Hindi | Z. Hassan | Ebtesam Qasem | A. K. Murugan | Mai Almohanna | Eman A. Humudh

[1] S. Mane,et al. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. , 2015, Human molecular genetics.

[2] Nikhil Wagle,et al. Response and acquired resistance to everolimus in anaplastic thyroid cancer. , 2014, The New England journal of medicine.

[3] Andrew H. Beck,et al. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. , 2014, Cancer discovery.

[4] M. Xing,et al. Molecular pathogenesis and mechanisms of thyroid cancer , 2013, Nature Reviews Cancer.

[5] Verena Albert,et al. mTOR in aging, metabolism, and cancer. , 2013, Current opinion in genetics & development.

[6] M. Xing,et al. Mutations in Critical Domains Confer the Human mTOR Gene Strong Tumorigenicity* , 2013, The Journal of Biological Chemistry.

[7] M. Xing,et al. Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 Mutations in Thyroid Cancers , 2011, Endocrine pathology.

[8] P. Hou,et al. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. , 2008, The Journal of clinical endocrinology and metabolism.

[9] M. Xing,et al. Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene. , 2011, Cancer research.